Related Experiment Videos
Malignant catatonia-induced respiratory failure with response to ECT
B K Boyarsky1, M Fuller, T Early
1Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch at Galveston 77555, USA.
The Journal of ECT
|September 24, 1999
Summary
Electroconvulsive therapy (ECT) effectively treated malignant catatonia in a schizophrenic patient with respiratory impairment. ECT resolved catatonia and improved psychosis, even with a tracheostomy, offering a vital treatment option.
Area of Science:
- Psychiatry
- Neurology
Background:
- Malignant catatonia is a life-threatening syndrome often associated with antipsychotic medication.
- This case involved a patient with a history of neuroleptic malignant syndrome (NMS), necessitating avoidance of traditional neuroleptics.
Observation:
- The patient presented with acute psychosis, schizophrenia, and severe catatonic symptoms including agitation, retardation, and rigidity.
- Despite discontinuation of neuroleptics and treatment with reserpine, dantrolene, bromocriptine, and lorazepam, the catatonia progressed, leading to respiratory impairment, intubation, and tracheostomy.
Findings:
- Eleven bilateral electroconvulsive treatments (ECT) were administered.
- ECT successfully resolved the patient's respiratory impairment and catatonia.
- ECT also led to significant improvement in the patient's psychotic symptoms.
Implications:
- This case underscores the efficacy of ECT as a critical intervention for lethal catatonia, particularly in medically complex patients.
- ECT can be safely and effectively utilized even in the presence of respiratory compromise and tracheostomy.
- The findings suggest ECT should be strongly considered in refractory cases of malignant catatonia unresponsive to other treatments.